Clinical outcomes in patients with adamantinoma: Report from the bone and soft tissue tumor registry in Japan

Author:

Shimizu Junya1ORCID,Emori Makoto1ORCID,Murahashi Yasutaka1ORCID,Kawai Akira2,Teramoto Atsushi1

Affiliation:

1. Department of Orthopaedic Surgery Sapporo Medical University School of Medicine Sapporo Japan

2. Department of Musculoskeletal Oncology and Rehabilitation Medicine National Cancer Center Hospital Tokyo Japan

Abstract

AbstractBackgroundAdamantinomas are rare malignant bone tumors. Due to their low incidence, there are few reports on the clinical results of adamantinoma.ObjectivesThis study aims to clarify outcomes in patients with adamantinoma using data from the National Bone and Soft Tissue Tumor Registry.MethodsFrom 2006 to 2019, 38 cases of tibial origin were included. Twenty‐four were male and 14 were female, with a mean age of 37 (6–87) years and a mean follow‐up of 35 (1–128) months.ResultsSurgery was performed in 33 cases (87%) (curettage: 4 cases, wide resection: 27 cases, amputation: 2 cases). Reconstruction was performed in 27 patients who underwent wide resection. A total of 12 additional surgeries were performed in 11 patients. The main reason for the additional surgeries was nonunion of grafting bone in 6 cases. Oncologic outcomes were DOC (death from other causes) in one case and NED (no evidence of disease) in 37 cases.ConclusionsThe results of treatment of adamantinomas in Japan have been extremely favorable. This may be due in part to the large number of cases with wide resection.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3